eflapegrastim-xnst 13.2 MG per 0.6 ML Prefilled Syringe

RxCUI: 2612541
RxNorm name: eflapegrastim-xnst 13.2 MG per 0.6 ML Prefilled Syringe
Display name: eflapegrastim-xnst 13.2 MG per 0.6 ML Prefilled Syringe
Full name: eflapegrastim-xnst 13.2 MG per 0.6 ML Prefilled Syringe
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:03

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761148	Rolvedon	eflapegrastim-xnst	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Rolvedon	EFLAPEGRASTIM-XNST	Spectrum Pharmaceuticals, Inc.	6e436115-62e7-4729-aeb0-ff78ea685206	2026-02-18	Warnings, Adverse reactions	Exact identifier rxcui: 2612541
Rolvedon	EFLAPEGRASTIM-XNST	Assertio Specialty Pharmaceuticals, LLC	2dc62c46-bb10-4a62-a459-d3eeeb6dd82f	2026-02-11	Warnings, Adverse reactions	Exact identifier rxcui: 2612541

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
6e436115-62e7-4729-aeb0-ff78ea685206	eflapegrastim-xnst 13.2 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML eflapegrastim-xnst 22 MG/ML Prefilled Syringe [SCD] · eflapegrastim-xnst 13.2 MG per 0.6 ML Prefilled Syringe [SY]	3	6	These highlights do not include all the information needed to use ROLVEDON ® safely and effectively. See full prescribing information for ROLVEDON. ROLVEDON ® (eflapegrastim-xnst) injection, for subcutaneous use Initial U.S. Approval: 2022	20260218
2dc62c46-bb10-4a62-a459-d3eeeb6dd82f	eflapegrastim-xnst 13.2 MG in 0.6 ML Prefilled Syringe [PSN] · 0.6 ML eflapegrastim-xnst 22 MG/ML Prefilled Syringe [SCD] · eflapegrastim-xnst 13.2 MG per 0.6 ML Prefilled Syringe [SY]	3	2	These highlights do not include all the information needed to use ROLVEDON ® safely and effectively. See full prescribing information for ROLVEDON. ROLVEDON ® (eflapegrastim-xnst) injection, for subcutaneous use Initial U.S. Approval: 2022	20260211